Our lab is hosting the multi-center FeraSafe Safety Registry study.
FeraSafe aims to investigate the use of Ferumoxytol, an FDA-approved molecule traditionally used to treat anemia, as a contrast agent for MRI. We have been evaluating the use of this agent for over 10 years to enhance cardiac imaging while prioritizing patient safety.
Want to learn more?
More about FeraSafe
